BFRIWBiofrontera Inc. Warrants
0.0293USD-0.34%Mkt Cap: —P/E: —3d ago
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL l…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)43.20M $
Gross Profit30.74M $
Net Income (TTM)-10.54M $
Revenue/Share3.973 USD
Last Price0.0293 USD
Fiscal Year End—
MR Quarter—
Employees84
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.07
EPS (TTM)-1.30
EPS (Forward)—
52W Range
0.020120% of range0.0660
52W High0.0660 USD
52W Low0.0201 USD
Profitability
Gross Margin73.71%
Oper. Margin-38.95%
EBITDA Margin-24.45%
Profit Margin-25.26%
ROE-100.53%
ROA-36.89%
Growth
Revenue Growth17.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.36M $
CapEx (TTM)2.00K $
FCF Margin3.42%
FCF Yield—
Net Debt1.40M $
Net Debt/EBITDA-0.13
Balance Sheet
Debt/Equity0.59
Current Ratio1.21
Quick Ratio0.99
Book Value/Sh0.4190 USD
Cash/Share0.4940 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float9.16M
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta0.80
S&P 52W Chg18.16%
Avg Vol (30d)5.34K
Avg Vol (10d)—
Technical Indicators
RSI (14)48.4
MACD-0.0036
MACD Signal-0.0040
MACD Hist.+0.0004
BB Upper0.0476 USD
BB Middle0.0302 USD
BB Lower0.0128 USD
BB Width115.13%
ATR (14)0.0087 USD
Vol Ratio (20d)0.02x